TOP TIERMARKET NEWSWIRE
Movers explained · October 20, 2026

Why Is ORIC PHARMACEUTICALS (ORIC) Stock Up Today?

By the Top Tier Newswire AI Desk · reviewed against 2 wire stories

ORIC PHARMACEUTICALS (ORIC) is up +9.63% in the latest session. Our newswire has captured 2 stories on ORIC across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 53/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

The written analysis for ORIC publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.

ORIC by the numbers

Last: $13.95Session: +9.63%Coverage: 2 stories / 2 sourcesAI sentiment: 53/100 (mixed)
AI sentiment, last 36h · averaged over 2 stories · 53/100 neutral
AI sentiment 53/100 (neutral)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 2 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agonowGlobeNewswire · sentiment 53 · ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026GlobeNewswire · 53ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being …Business Insider · sentiment 53 · ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026Business Insider · 53ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being …
1d agoGlobeNewswireNEUTRAL 53Product/PR

ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026

Conference call and webcast to take place on Friday, October 23, 2026, at 8:00 a.m. ET Event to feature Dr. Joshua Sabari to discuss enozertinib clinical data and the potential of enozertinib to treat...

1d agoBusiness InsiderNEUTRAL 53Product/PR

ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026

Conference call and webcast to take place on Friday, October 23, 2026, at 8:00 a.m. ET Event to feature Dr. Joshua Sabari to discuss enozertinib clinical data and the potential of enozertinib to treat...

Frequently asked questions

Why is ORIC stock up today?

ORIC PHARMACEUTICALS (ORIC) is up +9.63% in the latest session. Our newswire has captured 2 stories on ORIC across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 53/100). The most recent driver: "ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026" (GlobeNewswire).

Is ORIC a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of ORIC coverage reads 53/100 over 2 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.

More moves explained today

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on ORIC: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.